OPIANT PHARMACEUTICALS

opiant-pharmaceuticals-logo

Opiant Pharmaceuticals, with its team of addiction experts, is headquartered in Santa Monica, California. The Company, formerly known as Lightlake Therapeutics, was founded in 2009 by the late Dr. David Sinclair based on his pioneering research demonstrating that opioid antagonists could be used as a symptom-driven treatment for alcoholism

#SimilarOrganizations #People #Financial #Website #More

OPIANT PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2009-01-01

Address:
Santa Monica, California, United States

Country:
United States

Website Url:
http://www.opiant.com

Status:
Active

Contact:
+1 310 598 5410

Email Addresses:
info@opiant.com

Total Funding:
52 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin


Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

frontier-biotechnologies-logo

Frontier Biotechnologies

Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.

leap-therapeutics-logo

Leap Therapeutics

Leap Therapeutics is a clinical-stage biopharmaceutical company.

not_available_image

Oclassen Pharmaceuticals

Oclassen Pharmaceuticals, Inc. was acquired by Watson Pharmaceuticals Inc.

saol-therapeutics-logo

Saol Therapeutics

Saol Therapeutics is a biotech pharmaceutical company.


Current Advisors List

lorianne-masuoka_image

Lorianne Masuoka Director Board Of Directors chairman R&D committee @ Opiant Pharmaceuticals
Board_member
2021-03-01

Current Employees Featured

roger-crystal_image

Roger Crystal
Roger Crystal Chief Executive Officer @ Opiant Pharmaceuticals
Chief Executive Officer

phil-skolnick_image

Phil Skolnick
Phil Skolnick Chief Scientific Officer @ Opiant Pharmaceuticals
Chief Scientific Officer

matthew-ruth_image

Matthew Ruth
Matthew Ruth Chief Commercial Officer @ Opiant Pharmaceuticals
Chief Commercial Officer
2021-07-01

Investors List

biomedical-advanced-research-and-development-authority-barda_image

Biomedical Advanced Research and Development Authority (BARDA)

Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Opiant Pharmaceuticals

pontifax_image

Pontifax

Pontifax investment in Debt Financing - Opiant Pharmaceuticals

Official Site Inspections

http://www.opiant.com Semrush global rank: 4.99 M Semrush visits lastest month: 1.69 K

  • Host name: 45.60.103.106
  • IP address: 45.60.103.106
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Opiant Pharmaceuticals"

Indivior to Acquire Opiant Pharmaceuticals

Nov 14, 2022 “This transaction combines Opiant with an organization that shares our patient-focused mindset, and we believe creates immediate value for patients, our employees and our …See details»

Opiant Pharmaceuticals - Crunchbase Company Profile …

Opiant Pharmaceuticals is a pharmaceutical company that develops treatments for drug overdose and addictions leveraging intranasal and injectable delivery …See details»

Indivior | About Us - Opiant

About Us Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for opioid use disorder.See details»

Indivior | Our Leadership - Opiant

During her tenure she led multiple executive and organization transformations, mergers and divestitures, and implemented a highly effective CEO and executive succession program. …See details»

Indivior To Acquire Opiant Pharmaceuticals - PR Newswire

Nov 14, 2022 Under the terms of the merger agreement, Indivior will acquire all outstanding shares of Opiant for upfront consideration of $20.00 per share in cash, plus up to $8.00 per …See details»

Opiant Pharmaceuticals - 2025 Company Profile - Tracxn

Feb 26, 2025 Opiant Pharmaceuticals. has raised funding over 4 rounds. Its first funding round was on Mar 07, 2016. What are the most recent funding rounds of Opiant Pharmaceuticals? …See details»

Opiant Pharmaceuticals - Ownership and Business Overview

Opiant Pharmaceuticals is a biopharmaceutical company developing treatments for addiction and drug overdose leveraging intranasal and injectable delivery technologies. Opiant …See details»

Opiant, maker of Narcan, to be acquired in $145 million deal

Nov 14, 2022 Opiant plans to complete the submission to the Food and Drug Administration for that drug by the end of the year. Indivior's upfront payment of $20.00 per share is a premium …See details»

Opiant Pharmaceuticals - Overview, News & Similar companies

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT - Get Rating) General Counsel Brian Gorman sold 1,313 shares of the stock in a transaction dated Thursday, January 5th. The stock was sold at …See details»

OPIANT - Crunchbase Company Profile & Funding

OPIANT is an IT company that specializes in web development, app development, software, web design, and project management services.See details»

15 Canadian companies that donate to non-profit organizations

This national charitable organization is dedicated to helping kids in financial need, aged four through 18, participate in organized sports and recreation such as hockey, dance, soccer and …See details»

Indivior | Results, Reports & Presentations - Opiant

Feb 20, 2025 Indivior PLC to Acquire Opiant Pharmaceuticals, Inc. Download Announcement (379KB) Download Presentation (632KB) Watch Video. October 27 2022. Q3 Financial …See details»

Opiant Pharmaceuticals - Craft

Mar 2, 2023 Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders. The Company …See details»

Opiant's Leadership Team - Team at Opiant - The Org

Opiant's Leadership Team. Opiant's Leadership Team includes Brian Gorman and 5 others. Edit team. Team members. Brian Gorman EVP, Corporate Development & General Counsel. David …See details»

Opiant Pharmaceuticals Inc | Reuters

Dec 6, 2022 The U.S. Food and Drug Administration on Monday approved Opiant Pharmaceuticals Inc's nasal spray for reversing opioid-related overdoses, expanding treatment …See details»

Opiant Pharmaceuticals, Inc. (Opiant Pharmaceuticals, Inc.) - 药物 …

The company also is counting on its new opioid overdose medicine, Opvee, a nasal spray which was approved 14 months ago after holding its own against Emergent’s market leader naloxone …See details»

abhay jain - IT HEAD - DATA MATICS - LinkedIn

Lead the change with Opiant Technology's Digital Transformation services. ... Invest in your employees with CETPA’s Corporate Training and take your Organization a step ahead …See details»

OpenAI picks labor icon Dolores Huerta and other philanthropy …

17 hours ago The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, …See details»

Organizational Performance Group - We help people work …

Customized Workshops for Your Organization. Our Clients; Publications, Podcasts, & More. Abundance Leaders, Our Latest Book. Blog. Publications. OPG Inspire. Contact Us (203) 288 …See details»

Debbie Oakley Professional Organizer | Woodbridge VA - Facebook

Professional organization services can be delivered efficiently and... Debbie Oakley Professional Organizer, Woodbridge, Virginia. 59 likes · 4 were here. Professional organization services …See details»

linkstock.net © 2022. All rights reserved